Challenges await pharma in 2019

  • A Kaiser Family Foundation poll last March found that 80 percent of the country believes that prescription drug prices are unreasonable.
  • Drug spending in the United States is slowing. Retail prescription drugs represent just 10 percent of the $3.5 trillion the nation spent on health care in 2017, according the Centers for Medicare & Medicaid Services. That’s an increase of just 0.4 percent.
  • 90 percent of prescriptions in the United States are less-expensive generic copies of brand-name drugs.
  • 83 percent of Americans insured by their employer had a plan with at least three prescription drug tiers, according to the Kaiser Foundation. The average co-pay for the highest tier was $110.
Continue reading